This is the authors' abstract. We don't add key points for this paper.
Sir It was with interest that we read the article by Brisanda et al. Two recent meta-analyses of RCTs examining the treatment of primary chronic anal fissure (CAF) concluded Botox injection (BTx) or topical GTN/calcium channel blockers had similar efficacies (33 versus 40 per cent healing rate at 3years) and they were only marginally superior to placebo1. Recurrence rates reached 33 per cent at 3 years. When comparing LIS with chemical sphincterotomy, surgery healed CAF in 85·4 per cent with recurrence rates of only 3 per cent at 2 year follow-up2. This cohort study examining patients with persistent CAF after LIS demonstrated that chemical sphincterotomy provided transient decrease in anal sphincter tone, enabling healing of recurrent CAF in 74 per cent of patients. We should like to invite the authors' comments with regards to the following: First, 80 patients over an 8-year period were unsuccessfully treated with LIS. This appears to be high recurrence rate and implies that inadequate surgery may have been performed. No comment was made with regards to what proportion of their clinical practice developed recurrent CAF. Secondly, this study could have been randomized to either another medical treatment or placebo injection. Thirdly, all patients had anal manometry before and after treatment. The use of anal manometry may distinguish between hypertonic sphincters and low-pressure sphincters (LPS). Analysis of patients with LPS with CAF would be interesting as we would argue that neither chemical nor surgical sphincterotomy would logically improve healing, and advancement flaps may be a superior treatment. Lastly, maintaining the integrity of the anal sphincters is paramount in the treatment of CAF. EAUS to assess adequacy of LIS did not appear to be a component in this study or in the studies examined by the two meta-analyses. Incontinence following LIS is associated with either extensive division of IAS or inappropriate division of the EAS3. Meta-analysis indicated that incontinence following LIS is 2·3 per cent and, similarly to BTx injection, is mostly transient. We would advocate the use of EAUS and ARP in every female (because occult anal sphincter injury occurs in 35 per cent of normal vaginal deliveries and 80 per cent with forceps deliveries4), and men with recurrent symptoms following LIS, before considering further procedures.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Singh et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: